Compositions comprising a serotonergic tryptamine compound
AssigneeCaamtech, Inc.
InventorAndrew R. CHADEAYNE
Life of this patent
Estimating the term…
Abstract
Disclosed herein are compositions comprising a serotonergic tryptamine compound, combinations thereof, and methods of using them for treating and preventing a variety of human conditions. In one embodiment, disclosed herein are new compositions and methods which comprise a therapeutically effective amount of a first purified psilocybin derivative and a therapeutically effective amount of a second compound. The second compound is selected from the group consisting of a second purified psilocybin derivative, a purified terpene, a serotonergic drug, an adrenergic drug, a dopaminergic drug, a purified erinacine, and a purified hericenone.
Claims6
A psilocybin derivative of formula A:
- wherein:
- one of R1, R2, and R3 is an electron pair or a hydrogen and the others of R1, R2, and R3 are each independently selected from an alkyl, an alkenyl, or an alkynyl;
- R5 is a carbonate ester;
- and
- R4, R6, R7, R8, R9, and R10 are each independently selected from an electron pair, a hydrogen, an alkyl, an alkenyl, an alkynyl, a phenyl, a halide, a hydroxyl, a carbonyl, an aldehyde, a haloformyl, a carbonate ester, a carboxylate, a carboxyl, an ester, a hydroperoxy, a peroxy, an ether, a hemiacetal, a hemiketal, an acetal, a ketal, an orthoester, a methylenedioxy, an orthocarbonate ester, carboxamide, an amine, an imine, an amide, an azide, an azo, a cyanate, a nitrate, a nitrile, an isonitrile, a nitrosooxy, a nitro, a pyridyl, a thiol, a sulfide, sulfinyl, a sulfonyl, a thiocyanate, a carbonothioyl, or a phosphate.
The psilocybin derivative of formula A, wherein one of R1, R2, and R3 is an electron pair and the others of R1, R2, and R3 are both an alkyl.
The psilocybin derivative of formula A, wherein one of R1, R2, and R3 is a hydrogen and the others of R1, R2, and R3 are both an alkyl.
Dependencies are inferred from the claim text.